Immunitas Therapeutics, a clinical stage precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, announced the appointment of...
MedPharm, a global topical and transdermal CDMO, announced that Lynn Allen has been named Chief Executive Officer (CEO), effective January 1, 2024.
Ms. Allen has more than...
SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, announced that RareCyte Inc., a precision biology company based in Seattle, Washington,...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
More than 5 million people worldwide are living with neurodegenerative disorders like Parkinson's disease and primary progressive multiple sclerosis. Researchers funded by the National...
